Details for 2017729694

Up to date per 01.04.2026

Actions

Title / Product Name

VERFAHREN ZUR HERSTELLUNG VON N-(5-(3-(7-(3-FLUORPHENYL)-3H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-INDAZOL-5-YL)PYRIDIN-3-YL)-3-METHYLBUTANAMID

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017729694

EP Publication Number

3464285

E-Number

1519912

Language

PCT Number

US17035411

Publication Date

10.04.2019 A

21.09.2022 B1

Registration Date

21.09.2022

AT Publication Date

15.10.2022

Application Date

01.06.2017

Registration Number

Priorities

01.06.2016

201662344170 P

07.11.2016

201662418657 P

IPC

C07D 471/04 20060101AFI20171208BHEP

Maximum Duration of Protection

01.06.2037

Owner

BioSplice Therapeutics, Inc.9360 Towne Centre Drive San Diego, CA 92121US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

KC, Sunil Kumar10504 Clasico Court San Diego CA 92127US

Information about Fees